Larvol Delta - Adial-Pharmaceuticals-Announces-Positive-PreClinical-Data-for-PNV2-as-a-Drug-Candidate-for-Triple-Negative-Breast-Cancer

PNV2 - Adial

https://www.globenewswire.com/news-release/2021/11/29/2342228/26135/en/Adial-Pharmaceuticals-Announces-Positive-Pre-Clinical-Data-for-PNV2-as-a-Drug-Candidate-for-Triple-Negative-Breast-Cancer.html

Nov 29, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next